期刊文献+

主要ABO血型不合NST后纯红细胞再生障碍性贫血2例报告及文献复习 被引量:2

原文传递
导出
摘要 目的探讨主要ABO血型不合非清髓性异基因外周血干细胞移植(NST)后纯红细胞再生障碍性贫血(PRCA)发生的机制及治疗对策。方法对1例非霍奇金淋巴瘤(NHL)和1例慢性粒细胞性白血病(CML)患者行NST治疗,2例患者血型均为O型,供体为HLA完全相合的同胞(血型均为A型)。结果2例患者NST获得成功,但分别于移植后2、3个月出现PRCA,经强的松、雄激素、大剂量丙种球蛋白、皮下注射重组人促红细胞生成素(EPO)治疗,PRCA均无明显的改善。2例患者停用环孢菌素A(CsA)后均发生慢性移植物抗宿主病(cGVHD),经普乐可复(FK506)免疫抑制治疗后,cGVHD控制,同时抗A凝集素很快下降至0,网织红细胞、血红蛋白上升。结论EPO、大剂量丙球对该组病例治疗无效。NST后一旦发生PRCA,应尽早停用CsA,cGVHD控制与PRCA的恢复相关。
出处 《苏州大学学报(医学版)》 CAS 北大核心 2009年第3期591-592,共2页 Suzhou University Journal of Medical Science
  • 相关文献

参考文献8

  • 1Lee JH, Lee KH, Kim S, et ol. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneie bone marrow transplantation[J]. Bone Marrow Transplant, 2002, 25(2):179- 184.
  • 2Mueller RJ, Stussi G, Odermatt B, et ol. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism[J]. Xenotransplantation, 2006,13(2):126-132.
  • 3Maschan AA, Skorobogatova EV, Balashov DN, et al. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia[J]. Bone Marrow Transplant,2002, 30(6):405-407.
  • 4Nittsu H, Takatsu H, Miura I, et al. Pure red cell aplasia induced by B19 parvovims during allogeneic bone marrow transplantation[J]. Rinsho Ketsueki, 1990, 31(9):1566-1571.
  • 5Musso M, Porretto F, Crescimanno A, et al. Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneie peripheral stem cell transplantation[J]. Bone Marrow Transplantation,2004,33(7):769-771.
  • 6Bolan CD, Leitman SF, Griffith LM, et al. Delayed donor red cell ehimerism and pure red cell aplasia following major ABO -incompatible nonmyeloablative hematopoietie stem cell transplantation[J]. Blood,2001,98(6):1687-1694.
  • 7章卫平,王健民,宋献民,冯曹波,钱宝华,丁晓勤.ABO血型不合异基因外周血干细胞移植对红系造血重建的影响[J].中华血液学杂志,2005,26(2):113-114. 被引量:7
  • 8范辉,靖彧,李红华,卢学春,于力.ABO血型不合异基因造血干细胞移植后并发纯红系再生障碍[J].中国实验血液学杂志,2008,16(2):364-367. 被引量:9

二级参考文献20

  • 1黄晓军,刘代红,许兰平,韩伟,江倩,陈育红,张耀臣,刘开彦,鲍立,陆道培.主要ABO血型不合异基因造血干细胞移植后纯红细胞再生障碍[J].中华血液学杂志,2005,26(9):548-550. 被引量:26
  • 2董陆佳,谢大鹤,陆道培,陈欢,高志勇,陈育红,吴彤,韩伟,张晓辉,赵艳丽.造血干细胞移植相关性肠道血栓性微血管病:临床病理学特征、诊断标准和治疗[J].中国实验血液学杂志,2006,14(2):327-331. 被引量:8
  • 3贾晋松,刘东平,黄晓军,吴彤,刘代红,张耀臣,苏宏,王静波,周葭蕤,刘强,殷宇明,孙瑞娟,段萱,陆道培.异基因造血干细胞移植后人类巨细胞病毒pp65的监测及疗效、危险因素分析[J].中国实验血液学杂志,2006,14(4):749-754. 被引量:10
  • 4Benjamin RJ,CImnors JM,McGurk s,et al.Prolonged rnthmid aplasia after major ABO misnmtehed transplantation for chmnie myelogenous leukemia.Biol Blood Marrow Transplant,1998,4:151-156.
  • 5Gmur JP,Burger J,Schaffner A,et al.Pure red cell aplasia of long duration complicating major ABO—ineompatible bone marrow transplantation Blood,1990,75:290-295.
  • 6Sniecinski IJ,Oien I,Petz LD,et al. Immunohematologic consequences of major ABO—mismatehed bone marrow transplantation. Transplantation,1988,45:530-534.
  • 7Lee JH,Lee KH,Kim S,et al.Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation .Bone Marrow Transplant,2000.25:179-184.
  • 8Bucker CD, Clift RA, Sanders JE, et al. ABO-incompatible marrow transplants. Transplantation, 1978 , 26:233 - 238
  • 9Lee JH, Lee KH, Kim S, et al. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO- incompatible allogeneic bone marrow transplatation. Bone Marrow Transplant, 2000,25 : 179 - 184
  • 10Bensinger WI, Buckner CD, Thomas ED, et al. ABO-incompatible marrow transplantats. Transplantation, 1982; 33:427 -429

共引文献13

同被引文献70

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部